{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q12778",
      "entity_text" : "FOXO1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04807",
      "entity_text" : "AS1842856",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Furthermore, the results of the western blot assay demonstrated that the expression levels of SIRT1, QKI 5, FOXO1 and PPARalpha were decreased in the model mice, and this was reversed by SRT1720; therefore, the inhibitor of FOXO1 (AS1842856) was used.",
  "reading_complete" : "2020-08-03T18:05:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:04:17Z",
  "trigger" : "inhibitor",
  "evidence" : [ "inhibitor of FOXO1 (AS1842856" ],
  "pmc_id" : "6365049",
  "score" : 0
}